|1.||Mourad, Pierre D: 2 articles (09/2015 - 01/2013)|
|2.||Liu, Quanhong: 2 articles (10/2011 - 07/2011)|
|3.||Lee, William M-F: 2 articles (05/2010 - 12/2007)|
|4.||Wood, Andrew K W: 2 articles (05/2010 - 12/2007)|
|5.||Bunte, Ralph M: 2 articles (05/2010 - 12/2007)|
|6.||Sehgal, Chandra M: 2 articles (05/2010 - 12/2007)|
|7.||Gellhorn, Alfred C: 1 article (09/2015)|
|8.||Gillenwater, Cody: 1 article (09/2015)|
|9.||Andrade, Thiago Antônio Moretti: 1 article (04/2013)|
|10.||Gomes, Fernanda Guzzo: 1 article (04/2013)|
|1.||Varicose Ulcer (Ulcer, Venous)
06/01/2010 - "In this study, the in vivo antitumor effect of the simultaneous dual-frequency ultrasound (1 MHz and 150 kHz) at low-level intensity (cumulative I(SATA) = 2.2W/cm(2); total energy density 3960J/cm(2); for 30 min sonication) in combination with the sonosensitizer of photofrin (PF) (sodium porfimer) was investigated in dose fractionation regime in a spontaneous murine model of breast adenocarcinoma in Balb/c mice. "
09/01/2011 - "To increase cavitation yield, the tumor region was sonicated for 2.5 min at simultaneous frequencies of 3 MHz (I(SATA)=2 W/cm(2)) and 28 kHz (I(SATA)=0.04 W/cm(2)). "
12/01/2007 - "The tumor was insonated (I(SATA) = 1.7 W cm(-2), 1 MHz, continuous output) for 3 min and the power Doppler observations of the pre- and postinsonation tumor vascularities were analyzed. "
07/01/2011 - "Tumors were irradiated with ultrasound (1.43MHz, I(SATA) 3W/cm(2), 3min) for three times at 8, 12 and 24h after 5.0mg/kg PPIX administration, respectively. "
10/01/2011 - "Three murine tumor models with distinct aggressiveness (S180, H-22 and EAC) were treated with 1.75MHz continuous ultrasound at an acoustic intensity (I(SATA)) of 1.4W for 3min in the presence of 20μg/ml hematoporphyrin. "
05/01/2010 - "After the intravenous injection of 0.2 mL ultrasound contrast agent (Definity), therapy (n = 15) was performed on 1-mL tumors for 3 min with low-intensity continuous ultrasound (3 MHz; 2.4 +/- 0.1 W cm(-2) [I(SATA)]); control mice (n = 17) received a sham treatment. "
|4.||Wounds and Injuries (Trauma)
05/01/1993 - "By healing the complicated wounds, SATA potentiated the occurrence of an inflammatory reaction and slowed down regeneration, whereas its oily solution failed to produce this effect."
05/01/1993 - "A course intravenous SATA (2 mg four times at an interval of 4 days) administration was found to stimulate epithelial regeneration and suppress the formation of connective tissue of uncomplicated skin wounds. "
05/01/1990 - "Wounds were either sham-treated (control group) or exposed to pulsed ultrasound (2 ms on, 8 ms off) at an intensity of 0.1 W cm-2 SATA (frequency either 0.75 MHz or 3.0 MHz). "
01/01/1990 - "Wounds were either sham-treated (control group) or exposed to ultrasound for 5 min daily at an intensity of 0.1 W/cm2 SATA (frequency either 0.75 MHz or 3.0 MHz). "
|5.||Bone Fractures (Bone Fracture)
|1.||Dihematoporphyrin Ether (Porfimer Sodium)
|3.||Silver Sulfadiazine (SSD)
|4.||salicylhydroxamic acid (SHAM)
|5.||Brain Natriuretic Peptide (Natrecor)